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Background: Dyslipidemia is present in people with diabetes as well as subjects with normal glucose tolerance
(NGT). The purpose of this study was to investigate the relationship between lipid profiles and β cell function in
Chinese individuals with NGT but without history of diabetes or prediabetes.
Methods: A total of 893 men and 1454 women aged 18–76 years living in Sichuan, China, who were not being
treated with lipid-lowering drugs were enrolled in this study. Insulin sensitivity (IR) was evaluated using the
homeostasis model assessment –IR (HOMA-IR), β-cell function was calculated by the following equation: ΔI30/
ΔG30/ HOMA-IR (ΔI30/ΔG30: the ratio of incremental glucose and insulin 30 min after glucose intake). Multivariate
linear regression analyses were performed to estimate the relationship between blood lipid and β cell function as
standardized coefficients (β).
Results: β cell function decreased in men and women with increasing age. We found inverse relationships
between β cell function and total cholesterol (TC) in men and women (β=−0.157 and −0.113, respectively, both
p < 0.001), low-density lipoprotein–cholesterol (LDL-C; β=−0.130 and −0.068, respectively, both p < 0.001),
TC/high-density lipoprotein–cholesterol (HDL-C) ratio (β=−0.084, p < 0.01 and −0.096, p < 0.001), and triglycerides
(TG) (women only; β=−0.053, p < 0.05). However, β cell function was not associated with HDL-C in men or women
(β=−0.034 and 0.000, respectively, both p > 0.05) or the TG/HDL-C ratio (β=−0.035 and −0.013, respectively, both
p > 0.05). β cell function was significantly worse in males than in females in all age groups, except in subjects
aged > 70 years.
Conclusions: Dyslipidemia is associated with dysfunction of pancreatic β cells in subjects with NGT and this is
particularly evident in people with elevated TC and LDL-C levels, especially males.
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Dyslipidemia, characterized by elevated low-density lipo-
protein–cholesterol (LDL-C), triglyceride (TG), and total
cholesterol (TC) levels, and lowered high-density lipo-
protein–cholesterol (HDL-C) levels [1,2], is a major risk
factor for cardiovascular disease. Some studies [3,4] have
documented that dysfunction of pancreatic β cells
caused by dyslipidemia precede the manifestation of type
2 diabetes mellitus (T2DM) and is an independent risk
factor for the development of T2DM. Furthermore, the
atherogenic lipid pattern is not only apparent in diabetic
and prediabetic individuals but also in individuals with
normal glucose tolerance (NGT). Although several stud-
ies have documented the impact of dyslipidemia on the
function and survival of β cells in subjects with hyper-
glycemia, the relationship between β cell function and
dyslipidemia in subjects with NGT remains to be clari-
fied. Moreover, few studies have compared β cell func-
tion between men and women in different age groups,
among subjects with dyslipidemia and NGT.
Our cross-sectional study, conducted between June
and September 2007, was designed to provide reliable
data on the relationship between β cell function and
lipid profiles in Chinese individuals without prior history
of diabetes or prediabetes.
In our study, the homeostasis model assessment of in-
sulin resistance (HOMA-IR) was used to estimate insu-
lin sensitivity. β-cell function was quantified as the ratio
of the incremental insulin to glucose responses over the
first 30 min during the Oral Glucose Tolerance Test
(OGTT ) (ΔI30/ΔG30). Insulin sensitivity is known to
be a critical modulator of the insulin response to a
stimulus, with insulin resistance increasing insulin re-
lease. Thus, dividing ΔI30/ΔG30 by the HOMA-IR gave
an adjusted measure of β-cell function (ΔI30/ΔG30/
HOMA-IR) that accounted for variation in insulin sensi-
tivity. This method has been used to assess β-cell func-
tion in previous large studies [5-8].
Methods
Subjects
This cross-sectional study was conducted as part of the
China National Diabetes and Metabolic Disorders Study
[9]. We used a multistage, stratified sampling method
to select a representative sample of persons 18 years of
age or older in the general population. The sampling
process was stratified according to geographic region,
degree of urbanization and economic development sta-
tus. In the first stage of sampling, the whole Sichuan
province was stratified into urban and rural areas. Two
sample points from urban areas and three from rural
areas were selected to be representative of the geo-
graphic and economic characteristics in their regions.
In the second stage, 2 street districts or rural villageswere randomly selected from each sample point, re-
spectively. Primary sampling units were street districts
in urban areas and hamlets in rural sample points. In
the third stage, one participant was selected from a ran-
domly selected household in the primary sampling
units. Simple random sampling methods were used at
each stage. A total of 3514 subjects, including 1400
men and 2114 women, aged 18–76 years, participated
in this survey between June and September 2007. Of
the 3514 participants, 2347 with NGT [fasting plasma
glucose (FPG) < 109.8 mg/dl, and 2-h post oral glucose
tolerance test plasma glucose < 140.4 mg/dl] [10], and
complete data were included in this study. Subjects
with diabetes or prediabetes [including isolated
impaired fasting glucose (IFG), isolated impaired glu-
cose tolerance (IGT), or IFG plus IGT] were excluded.
After enrollment, subjects were stratified by sex. There
were 2347 subjects ( 893 males and 1454 females),out
of which there were 349 postmenopausal women. At
present 45 subjects were on diuretics, 78 were on cal-
cium channel blocker (CCB) and 53 others were on
Angiotensin-Converting Enzyme Inhibitors (ACEI) or
Angiotensin Receptor Blocker (ARB) therapy.
The study was approved by the Drugs/Medical Appar-
atus & Instruments Ethics Committee at China Japan
Friendship Hospital (07020470055), and all subjects gave
their informed consent. This study was registered on the
Chinese clinical trial registry (#TR-CCH-Chi CTR-CCH-
00000361).
Study design
A standard questionnaire was administered by trained
staff to participants to record demographic characteris-
tics and lifestyle risk factors [11]. Blood pressure, body
weight, height, waist and hip circumference, body mass
index (BMI), and waist/hip ratio (WHR) were measured
and calculated using standard methods, as previously
described [9]. Participants were instructed to maintain
their usual physical activity and diet for at least 3 days
before undergoing an OGTT. After an overnight
fast ≥ 10 h, a venous blood specimen was collected to
measure FPG, fasting insulin and blood lipids (including
TC, TG, LDL-C, and HDL-C). Blood samples were also
drawn at 30 and 120 min after a 75 g glucose load to
measure glucose and insulin concentrations. The blood
samples were placed in an ice box and transported to
the laboratory of endocrinology and metabolism at West
China Hospital, Sichuan University, for analysis. Plasma
glucose levels were measured using a hexokinase enzym-
atic method. Insulin was measured by a radioimmuno-
assay with human insulin as a standard (Linco, St
Charles, MO). TG, TC, LDL-C, and HDL-C levels were
determined enzymatically. β cell function was calculated
from insulin and glucose levels determined at 0 and
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HOMA-IR, where the incremental glucose (ΔG30) and
insulin (ΔI30) responses were calculated as the differ-
ence in values between 30 and 0 min. The homeostasis
model assessment of insulin resistance (HOMA-IR) was
calculated from FPG and fasting insulin levels as
described by Matthews et al. [12] using the equation:
(FPG× fasting insulin) / 22.5.
Statistical analysis
All analyses were performed using SPSS software version
16.0 (SPSS Inc., Chicago, IL). Since the distributions of
fasting insulin, 0.5-h insulin, 2-h insulin, and TG were
skewed, these parameters were logarithmically trans-
formed before statistical analysis. Clinical and biochem-
ical characteristics were compared using Student’s t test
or χ2 tests. Sex-specific mean values of β cell function
were calculated for 10 mg/dl cut-off levels of TC (< 120,
120–139.9, 140–159.9, 160–179.9, 180–199.9, 200–
219.9, and >220 mg/dl; n = 47, 104, 173, 194, 158, 124,
and 93, respectively, for men; n = 65, 147, 319, 328, 264,
172, and 159, respectively, for women), for 25 mg/dl cut-
off levels of TG (< 74.9, 75–99.9, 100–124.9, 125–149.9,
150–174.9, 175–199.9, and > 200 mg/dl; n = 165, 193,
157, 103, 82, 68, and 125, respectively, for men; n = 364,
375, 260, 156, 106, 52, and 141, respectively, for women),
for 10 mg/dl cut-off levels of HDL-C (< 29.9, 30–39.9,
40–49.9, 50–59.9, 60–69.9, and > 70 mg/dl; n = 29, 201,
335, 205, 88, and 35, respectively, for men; n = 30, 204,
405, 444, 247, and 124, respectively, for women), for
15 mg/dl cut-off levels for LDL-C (< 84.9, 85–99.9, 100–
114.9, 115–129.9, 130–144.9, 145–159.9, and > 160 mg/
dl; n = 192, 166, 150, 132, 95, 74, and 84, for men;
n = 360, 315, 281, 220, 110, 94, and 74, respectively,
for women), for 0.5 unit cut-off levels of TC/HDL ratio
(< 2.49, 2.5–2.99, 3.0–3.49, 3.5–3.99, 4.0–4.49, 4.5–4.99,
and >5.0; n = 59, 138, 191, 180, 125, 90, and 110, respect-
ively, for men; n = 167, 316, 357, 241, 150, 111,and 112,
respectively, for women), for 1 unit cut-off levels of TG/
HDL ratio (< 1.49, 1.5–2.49, 2.5–3.49, 3.5–4.49, 4.5–5.49,
and > 5.5; n = 197, 262, 172, 102, 49, and 111, respectively,
for men; n = 482, 489, 196, 136, 65, and 86, respectively,
for women), and for 10-year age groups (< 30, 30–39,
40–49, 50–59, 60–69, and >70 years; n = 193, 229, 145,
151, 145, and 30, respectively, for men; n = 292, 355, 303,
265, 191, and 48, respectively, for women). Multiple
linear regression analyses were used to examine the
relationship between β cell function as the dependent
variable and blood lipid levels as independent vari-
ables. Standardized coefficients (β) were determined
after adjusting for age, family history of diabetes, level
of activity, BMI, smoking, and systolic blood pressure
(SBP). Multiple linear regression was also used to exam-
ine the relationship between β cell function and age,adjusting for family history of diabetes, level of activity,
BMI, smoking, and SBP. T tests were used to compare
sex-specific β cell function among subjects in different
age groups.
Results
Clinical and biochemical characteristics
Table 1 shows the sex-specific clinical and biochemical
characteristics. There were no differences in age, family
history of diabetes, regular leisure-time physical activity,
BMI, WC, SBP, FPG, 0.5-h plasma glucose, 2-h plasma
glucose, fasting insulin, TC, HDL-C, or LDL-C between
males and females. However, compared with women,
more men were smokers or consumed alcohol, they
more frequently had college education and higher in-
come, and they had higher WHR. Men also had lower
0.5-h insulin, 2-h insulin, and TG levels.
Relationship between β cell function and blood lipid
profiles
Multivariate linear regression analyses (Figure 1, Table 2)
showed inverse trends between β cell function and TC
in both men and women [β=−0.157 (corresponding to a
change in β cell function of 0.157 units for each 1-mg/dl
increase in FPG) and −0.113, respectively, both
p < 0.001], LDL-C (β=−0.130 and −0.068, respectively,
both p < 0.001), TC/HDL ratio (β=−0.084 and −0.096,
respectively, both p < 0.01), and TG in women
(β=−0.053, p < 0.05) after adjustment for potential con-
founding factors. On the other hand, β-cell function was
not associated with HDL-C in men or women
(β=−0.034 and −0.000, respectively, both p > 0.05) or
TG/HDL-C ratio (β=−0.034 and −0.000, respectively,
both p > 0.05).
Sex-specific β cell function according to age
Figure 2 shows sex-specific β cell function according to
age after adjustment for family history of diabetes, level
of activity, BMI, smoking, and SBP. This analysis showed
an inverse trend between β cell function and age in both
men and women (β=−0.166 and −0.127, respectively,
both p < 0.001). Table 3 shows that β cell function was
significantly worse in men than in women in all age
groups, except in subjects aged > 70 years.
Discussion
It is well established that cholesterol homeostasis is fun-
damental for appropriate insulin secretory function of β
cells [13,14], as excessive cholesterol accumulation in β
cells may cause lipotoxicity and reduce insulin secretion,
causing β cell dysfunction and decreased β cell mass
[15-17]. Some studies [18] have documented that people
with diabetes or prediabetes had higher TC levels when
compared with individuals with NGT. This might
Table 1 Subject characteristics*
Characteristic Men (n= 893) Women (n= 1454) p value
Age (years) 42.6 ± 14.9 43.3 ± 14.2 NS
Family history of diabetes (%) 11.9 12.3 NS
Cigarette smoking (%) 49.7 4.3 < 0.001
Alcohol drinking (%) 55.5 11.5 < 0.001
Education
College or above (%) 32.6 25.0 < 0.01
Middle school (%) 39.1 40.1 NS
Primary school or below (%) 28.3 34.9 < 0.01
Income (per year)
≥10000 yuan RMB (%) 32.7 27.6 < 0.01
<10000 yuan RMB (%) 67.3 72.4 < 0.01
Regular leisure-time physical activity (%) 58.5 62.6 NS
BMI (kg/m2) 22.7 ± 3.2 22.3 ± 3.4 NS
WC (cm) 81.1 ± 9.7 78.1 ± 9.8 NS
WHR 0.88 ± 0.08 0.82 ± 0.08 0.019
SBP (mmHg) 115.7 ± 16.5 111.3 ± 17.7 NS
fasting plasma glucose (mg/dl) 83.5 ± 9.6 83.2 ± 9.1 NS
0.5-h plasma glucose (mg/dl) 143.4 ± 30.4 135.7 ± 28.1 NS
2-h plasma glucose (mg/dl) 96.2 ± 21.6 99.3 ± 19.1 NS
Fasting insulin(μU/ml) 6.3 (4.4, 8.8) 6.6 (4.7, 9.3) NS
0.5-h insulin (μU/ml) 28.4 (13.2, 42.1) 33.2 (13.0, 48.2) < 0.01
2-h insulin (μU/ml) 15.2 (8.0, 28.8) 19.4 (11.3, 37.1) 0.023
TC (mg/dl) 173.9 ± 35 176.1 ± 38.2 NS
TG (mg/dl) 98.2 (74.3, 136.3) 112.4 (81.4, 165.5) 0.01
HDL-C (mg/dl) 48.2 ± 16.4 52.5 ± 13.9 NS
LDL-C (mg/dl) 106.3 ± 30.9 105.1 ± 31.9 NS
Data were expressed as means ± standard deviation, median (interquartile range), or percentage for normally distributed continuous various, abnormally
distributed continuous variables, and categorical variables, respectively. Abnormally distributed variables were logarithmically transformed before analysis.
Between-group comparisons were conducted using Student’s t test or χ2 tests. NS: not significant; BMI: body mass index; WC: waist circumference; WHR: waist/hip
ratio; SBP: systolic blood pressure; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein–cholesterol; LDL-C: low-density lipoprotein–cholesterol.
Cigarette smoking was defined as having smoked at least 100 cigarettes in one’s lifetime. Alcohol consumption was defined as consumption of≥ 30 g of alcohol
per week for 1 year or more. Regular leisure-time physical activity was defined as participation in≥ 30 min of moderate or vigorous activity per day at least 3 days
per week.
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state to overt T2DM, and subsequent deterioration of
T2DM. In our study, we found that β cell was inversely
associated with TC and LDL-C in men and women with
NGT, and that β cell function deteriorated with increas-
ing level of TC and LDL-C. On one hand, the reason
may be due to the deterioration of the pancreatic β cell
function aggravated by disorder in lipid metabolism, the
mechanisms for this change could be summarized as fol-
lows. First, the accumulation of cholesterol in β cells
decreases the expression of the transcription factors
pancreatic and duodenal homeobox 1 and β cell E-box
trans-activator 2, both of which are important in β cell
development and survival [19]. Second, high β cell chol-
esterol levels interfere with glucose metabolism byreducing the effectiveness of the insulin secretory appar-
atus and inhibiting glucokinase activity [14]. Third,
increased cholesterol levels in β cells may lead to defi-
cient ATP-binding cassette transporter A1 (ABCA1) ac-
tivity, which promotes cholesterol efflux from cells to
lipid-free/lipid-poor apolipoprotein A-I in the extracellu-
lar space [13]. Recent studies [20] have also demon-
strated that LDL-C inhibits glucose-stimulated insulin
secretion and β cell proliferation through LDL-receptor
dependent and independent mechanisms, respectively.
Furthermore, Roehrich et al. [21] reported that high
LDL-C levels (> 6 mmol/l) induce apoptosis of β cells.
On the other hand, as our study is a cross-sectional
study, the results may also be due to impaired pancreatic
β cell functions which in turn lead to lipid metabolism
Figure 1 Associations between β cell function and blood lipid parameters in men and women with normal glucose tolerance.
Standardized coefficients (β) were estimated after adjusting for age, body mass index, smoking, and systolic blood pressure, leisure-time physical
activity, family history of diabetes. *p < 0.05 and **p < 0.01.
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stages of impaired islet β-cell function. Previous studies
have confirmed that under the presence of insulin resist-
ance, suppression of FFA by insulin is reduced and the
increased level of FFA will enhance small dense LDL
level whereas the overall level of LDL-C will be less
affected [22]. Our data appear to provide further evi-
dence that elevated levels of TC and LDL-C is associated
with β cell dysfunction in subjects with NGT, as well as
in people with diabetes or prediabetes. But we still needmore prospective studies to clarify the relationship be-
tween pancreatic islet β-cell dysfunction and disorders
in lipid metabolism.
Several in vivo and in vitro studies [23,24] have shown
that hypertriglyceridemia diminishes glucose-induced in-
sulin secretion via the glucose–fatty acid cycle in which
fatty acid oxidation inhibits glucose oxidation by de-
creasing pyruvate dehydrogenase (PDH) activity and in-
creasing PDH kinase activity. Moreover, elevated TG
levels induce β cell apoptosis by increasing the levels of
Table 2 Multiple linear regression analyses of variables associated with β cell function in NGT subjects
Male Female Male Female Male Female Male Female Male Female Male Female
variables β P β P β P β P β P β P β P β P β P β P β P β P
TC (mg/dl) −0.157<0.001−0.113<0.001 - - - - - - - - - - - - - - - - - - - -
TG (mg/dl) - - - - −0.0170.742 −0.0530.045 - - - - - - - - - - - - - - - -
HDL-C (mg/dl) - - - - - - - - −0.0340.345 0.000 0.885 - - - - - - - - - - - -
LDL-C (mg/dl) - - - - - - - - - - - - −0.130<0.001−0.068<0.001 - - - - - - - -
TC/HDL-C - - - - - - - - - - - - - - - - −0.084<0.01 −0.096<0.001 - - - -
TG/HDL-C - - - - - - - - - - - - - - - - - - - - −0.0130.698 −0.0350.181
Age(year) −0.115<0.01 −0.0780.010 −0.135<0.001−0.092<0.01−0.135<0.01 −0.095<0.01−0.125<0.001−0.090<0.01 −0.124<0.001−0.0770.01 −0.134<0.001−0.094<0.01
BMI (kg/m2) 0.098 <0.01 −0.0390.194 0.062 0.098 0.041 0.176 0.061 0.088 −0.0430.150 0.081 0.024 −0.0420.164 0.084 0.021 −0.0360.230 0.065 0.077 −0.0420.158
SBP (mmHg) −0.0550.133 −0.0410.174 −0.0720.052 −0.0490.098 −0.0700.057 −0.0510.089 −0.0670.067 −0.0480.106 −0.0690.060 −0.0520.080 −0.0720.052 −0.0500.095
Smoking −0.253<0.001−0.0480.089 −0.265<0.001−0.0490.084 −0.261<0.001−0.0480.086 −0.258<0.001−0.0480.085 −0.272<0.001−0.0460.104 −0.265<0.001−0.0490.084
Leisure-timephysical activity 0.169 <0.0010.045 0.092 0.162 <0.01 0.055 0.037 0.161 <0.01 0.056 0.036 0.173 <0.0010.052 0.051 0.166 <0.0010.058 0.028 0.162 <0.01 0.055 0.039



















Figure 2 Association between β cell function and age in men and women with normal glucose tolerance. Standardized coefficients (β)
were estimated after adjusting for family history of diabetes, level of activity, BMI, smoking, and SBP. *p < 0.05 and **p < 0.01.
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can also lead to elevated TG levels, the mechanism
could be that under the insulin resistance condition, de-
crease in LPL activity and excessive increase in VLDL
level will eventually reduce the decomposition in chylo-
microns (CM) [27]. However, the association between
β cell function and TG in our study was weaker than the
associations of β cell function with TC or LDL-C, and the
association was only apparent in women. There are several
possible reasons for this discrepancy. First, TG levels fluctu-
ate widely depending on recent dietary intake or weight
changes; some of the enrolled subjects may not have fol-
lowed our instructions strictly and consumed foods rich in
TG before blood sampling. Second, there may be sex differ-
ence in TG levels meaning further studies are needed.
Third, compared with TC and LDL-C, TG may exert
weaker effects on β cell function in subjects with NGT.
Regarding HDL-C, we did not find any evidence for a
relationship between HDL-C and β cell function. Al-
though previous studies have shown that HDL-C stimu-
lates insulin secretion by interacting with ABCA1, the
ATP-binding cassette transporter G1, or scavenger re-
ceptor B1, it also inhibits apoptosis of β cells [4]. Other
pre-diabetes and diabetes population studies also showedTable 3 Comparison of β cell function between men and
women according to age
Age (years) n (male:female) β cell function p value
Men Women
< 30 485 (193:292) 11.0 ± 5.8 14.8 ± 7.2 < 0.001
30-39 584 (229:355) 10.1 ± 4.9 13.2 ± 5.8 < 0.01
40-49 448 (145:303) 7.8 ± 3.9 11.8 ± 4.3 < 0.001
50-59 416 (151:265) 7.2 ± 3.7 9.3 ± 4.1 0.01
60-69 336 (145:191) 6.6 ± 2.8 10.5 ± 3.8 < 0.01
> 70 78 (30:48) 8.0 ± 3.1 9.6 ± 4.2 NS
Data are expressed as means ± standard deviation. Between-group
comparisons were conducted using Student’s t test.that the pancreatic β cell dysfunction can lead to eleva-
tion in HDL-C levels, and the mechanism may be asso-
ciated with alteration in VLDL catabolism, decrease in
apolipoprotein AI (ApoAI) levels and insufficient LPL
functions. At present time few research has been done
on the the NGT group regarding the relationship be-
tween pancreatic β cell function and HDL-C, and the
results of our study are inconsistent with previous
researches done in the impaired glucose tolerance
groups. The specific reason for this inconsistency is still
unknown, it was estimated that HDL-C may play an im-
portant role in protecting β cells in relatively late stages
of disease, particularly in IFG, IGT, or T2DM, while its
protective effects in NGT are less apparent. Further
studies are needed to examine the relationship between
β cell function and HDL-C in subjects with NGT, IFG,
IGT, and T2DM.
Our data indicate that β cell function is impaired not
only in people with IFG, IGT, or T2DM, but also in indi-
viduals with NGT and dyslipidemia, particularly in sub-
jects with elevated levels of TC and LDL-C. Compared
with TG and HDL-C, TC and LDL-C have a more sig-
nificant relationship with pancreatic β cell functions at a
relatively early stage. Consequently, high levels of TC
and LDL-C in NGT subjects with impaired β cell func-
tion should be paid more attention. We believe that ex-
ercise and diet therapy should be preferred to these
people first because these two modalities of treatment
have clear effect in alleviating insulin resistance and
blood lipids metabolism disorder. Whether the incidence
of developing diabetes or atherosclerosis is higher in
these group than normal individuals and whether the
treatment for these people using lipid lowering agents or
drugs increasing insulin sensitivity have not been clear
yet, we still need more prospective studies to make fur-
ther confirmation.
The TC/HDL-C and TG/HDL-C ratios are both recog-
nized as effective predictors of cardiovascular disease
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the TG/HDL-C ratio is associated with insulin resistance
and may be used with other risk factors to identify sub-
jects at increased risk of insulin resistance-driven mor-
bidity. In assessment of β cell function, however, our
analysis revealed that the TC/HDL-C ratio, but not TG/
HDL-C ratio, increased with decreasing β cell function.
Reasons for this difference may be include differences in
diet, sex, or other factors.
Our finding that β-cell function decreased in men and
women with increasing age is consistent with the results
of other studies [18,31]. Interestingly, we also found that
β cell function was significantly worse in males than in
females in each age group, except in subjects
aged > 70 years. Different levels of blood lipids in males
and females in each age group may partly explain these
sex differences. Previous studies have already reported
different changes in blood lipids between men and
women with increasing age. For example, the Lipid Re-
search Clinics Program Study [31], a cross-sectional
study of a North American Caucasian population,
showed that TC increased with age up to the age of 50–
54 years in men but declined with age up to 55–59 years
in women. By contrast, both TC and TG increased with
age up to the oldest age group of 55–59 years in both
sexes. The trends in blood lipid levels in men and
women with age in Chinese individuals are still not fully
understood and may differ from those in western popu-
lations. Clearly, prospective studies in China are needed
to further investigate these trends. Notably, however,
Yang et al. [9] reported that the prevalence rates of dia-
betes (10.6% vs. 8.8%) and prediabetes (16.1% vs. 14.9%)
were higher in men than women. These results indicate
that males with NGT and dyslipidemia should be paid
more attention than females.
Our study has several limitations. First, β cell function
did not differ between males and females > 70 years of
age. This may due to the relatively small number of sub-
jects in this age group, and could be overcome by in-
creasing the number of subjects in this age group.
Second, because of the cross-sectional design, we cannot
further clarify the mutual interaction between the dis-
order in lipid metabolism and pancreatic β cell
dysfunction.Conclusions
Dyslipidemia is associated with dysfunction of pancreatic
β cells in subjects with NGT and this is particularly evi-
dent in people with elevated TC and LDL-C levels, espe-
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